CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 111 Inc - ADR is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

111 Inc - ADR
3-4/F
No.295 Zuchongzhi Road, Pudong New Area
Phone: +86 2120536666p:+86 2120536666 SHANGHAI, SHA  201203  China Ticker: YIYI
Business Summary
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023YesYes---

Industries
SIC Code Description
5912 Drug stores and proprietary stores
5122 Drugs, drug proprietaries, and druggists' sundries
5961 Catalog and mail-order houses
7375 Information retrieval services
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman GangYu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder JunlingLiu 59 1/1/2015 1/1/2015
Chairman & Chief Executive Officer JunlingLiu
10 additional Officers and Directors records available in full report.

Business Names
Business Name
1 Pharmacy Technology (Shanghai) Co., Ltd.
Chongqing Yihao Pharmacy Co., Ltd.
Hubei Yihao Pharmacy Co., Ltd.
10 additional Business Names available in full report.

General Information
Number of Employees: 1,520 (As of 12/31/2023)
Outstanding Shares: 171,328,644 (As of 6/30/2024)
Stock Exchange: NASD


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024